🇺🇸 FDA
Patent

US 12091397

Dihydroquinolinones for medical treatment

granted A61KA61K31/4375A61K31/4704

Quick answer

US patent 12091397 (Dihydroquinolinones for medical treatment) held by C4 THERAPEUTICS, INC. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4 THERAPEUTICS, INC.
Grant date
Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4375, A61K31/4704, A61K47/55, A61P